Catheter Precision Inc (AMEX:VTAK)’s traded shares stood at 2.1 million during the last session, with the company’s beta value hitting -0.42. At the close of trading, the stock’s price was $0.48, to imply an increase of 10.47% or $0.05 in intraday trading. The VTAK share’s 52-week high remains $8.40, putting it -1650.0% down since that peak but still an impressive 35.42% since price per share fell to its 52-week low of $0.31. The company has a valuation of $1.35M, with an average of 0.46 million shares in intraday trading volume over the past 10 days and average of 3.50 million shares over the past 3 months.
Catheter Precision Inc (AMEX:VTAK) trade information
After registering a 10.47% upside in the last session, Catheter Precision Inc (VTAK) has traded red over the past five days. The 5-day price performance for the stock is 2.11%, and 28.71% over 30 days. With these gigs, the year-to-date price performance is -88.13%. Short interest in Catheter Precision Inc (AMEX:VTAK) saw shorts transact 0.18 million shares and set a 0.02 days time to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Catheter Precision Inc (VTAK) estimates and forecasts
Looking at statistics comparing Catheter Precision Inc share performance against respective industry, we note that the company has outperformed competitors. Catheter Precision Inc (VTAK) shares are -91.87% down over the last 6 months, with its year-to-date growth rate higher than industry average at 92.80% against 15.90%. The rating firms project that company’s revenue will grow 621.70% compared to the previous financial year.
Revenue forecast for the current quarter as set by 1 analysts is 1.06M. Meanwhile, for the current quarter, a total of 1 analyst(s) estimate revenue growth to 1.66M.Earnings reports from the last fiscal year show that sales brought in 133k and 128k respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 697.00% before jumping 1,196.90% in the following quarter.
VTAK Dividends
Catheter Precision Inc has its next earnings report out in December. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Catheter Precision Inc (AMEX:VTAK)’s Major holders
Catheter Precision Inc insiders hold 13.53% of total outstanding shares, with institutional holders owning 5.63% of the shares at 6.51% float percentage. In total, 5.63% institutions holds shares in the company.
